• Clinical Services
  • Market Registration
    •  
    		 
     
     

    Defining & Capitalizing on the Opportunity

    China Clinical Services

    Understanding the China market opportunities and challenges allows Accelovance to optimize value for sponsors relative to the following needs:

  • Troubled Study Due to Recruitment
  • Planned Study in Difficult to Recruit Indications (Oncology, Hepatitis, Infectious Disease, etc.)
  • Seeking New Markets
  • Seeking Economic Value
  • Proof-of-Concept Clinical Studies (Phase I Completed in West)
  • Fulfill Demographic Requirement

    • Services

    Accelovance (China) operates to deliver ICH-GCP compliant clinical trials. Its staff has strong experience in conducting ICH-GCP clinical trials for multinational client and it utilizes the same clinical SOPs as U.S. based Accelovance, Inc.. Depending on your needs, Accelovance (China) offers the following services:

  • Regulatory
  • Project Management
  • Monitoring
  • Quality Control/Study Coordination
  • Data Management/Biostatistics
  • Market Commercialization

    • Value

    Based on a thorough understanding of your needs, Accelovance is committed to deliver high quality services to help you realize your goals. We look to build long-term relationships and be viewed as a valued partner in your success.

  • High Quality & Cost Effective Studies
  • Revenue with Market Entry

    • Market Registration Services

    With a presence in both the United States and China, Accelovance can facilitate the establishment of relationships necessary to optimize a products' revenue potential in the China market. Emphasizing value to its pharmaceutical partners, Accelovance is flexible in the way it structures relationships/partnerships. These structures may include the development of Joint Ventures, Licensing, and/or Broker/Agent. This approach affords partners the opportunity to increase their revenues with as little or as much involvement as they require or have resources to commit.

    Accelovance will use its expertise, industry knowledge and its high level government and industry relationships to comprehensively move a product through the following key areas into China’s pharmaceutical marketplace.

    • Market Research
      • Legal (IP, Trademark, etc.)
      • Partner Evaluation/Selection
      • Relationship Structure (JV, Licensing)
      • Develop JV/Partnership Management Structure
    • Business Formation
    • Import Drug Registration
    • Manufacturing/Packaging
    • Marketing & Sales
    • Distribution

    Drug development companies can take advantage of the tremendous opportunity in China to increase revenues by entering the world’s fastest growing market. At $7 billion, China is currently the seventh largest pharmaceutical market globally; however, projections from Boston Consulting Group data indicate it will be fifth by 2010 at $24 billion, and some believe in the top three by 2020 at an estimated $120 billion.

    Back to Top
     

    		   
     
     
    About | US Services | China Services | Press & Events | Careers | Contact | Home
    2007© Accelovance, Inc. All rights reserved.